Interestingly, Liu et al. combined chemotherapy with gene therapy by co-delivering DOX with a linear tumor therapeutic gene (p53) and a DNA origami targeting a multidrug-resistant tumor (MCF-7R) [50]. Here, TP53 is linked to neoplasm.